- Home
- BIOA vs UCL Comparison
BIOA vs UCL Comparison
Compare BIOA & UCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BIOA
- UCL
- Stock Information
- Founded
- BIOA 2015
- UCL 2014
- Country
- BIOA United States
- UCL Hong Kong
- Employees
- BIOA N/A
- UCL 404
- Industry
- BIOA Biotechnology: Pharmaceutical Preparations
- UCL Telecommunications Equipment
- Sector
- BIOA Health Care
- UCL Consumer Discretionary
- Exchange
- BIOA Nasdaq
- UCL Nasdaq
- Market Cap
- BIOA 155.2M
- UCL 144.5M
- IPO Year
- BIOA 2024
- UCL 2020
- Fundamental
- Price
- BIOA $4.55
- UCL $3.91
- Analyst Decision
- BIOA Hold
- UCL
- Analyst Count
- BIOA 4
- UCL 0
- Target Price
- BIOA $5.67
- UCL N/A
- AVG Volume (30 Days)
- BIOA 91.6K
- UCL 238.7K
- Earning Date
- BIOA 08-06-2025
- UCL 08-13-2025
- Dividend Yield
- BIOA N/A
- UCL N/A
- EPS Growth
- BIOA N/A
- UCL N/A
- EPS
- BIOA N/A
- UCL 0.02
- Revenue
- BIOA $3,863,000.00
- UCL $89,277,000.00
- Revenue This Year
- BIOA N/A
- UCL $6.09
- Revenue Next Year
- BIOA N/A
- UCL $7.01
- P/E Ratio
- BIOA N/A
- UCL $166.33
- Revenue Growth
- BIOA N/A
- UCL 3.72
- 52 Week Low
- BIOA $2.88
- UCL $0.80
- 52 Week High
- BIOA $26.62
- UCL $4.19
- Technical
- Relative Strength Index (RSI)
- BIOA N/A
- UCL 74.41
- Support Level
- BIOA N/A
- UCL $3.15
- Resistance Level
- BIOA N/A
- UCL $4.10
- Average True Range (ATR)
- BIOA 0.00
- UCL 0.40
- MACD
- BIOA 0.00
- UCL 0.10
- Stochastic Oscillator
- BIOA 0.00
- UCL 85.03
About BIOA BioAge Labs Inc. Common Stock
Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biology of human aging. Its focus is metabolic disease, one of the greatest healthcare challenges. The pipeline Products of the company are NLRP3 inhibitors, APJ against, and others.
About UCL uCloudlink Group Inc.
Ucloudlink Group Inc is engaged in the provision of data connectivity services and sales of Wi-Fi terminals and data related products to enable personal and enterprise users to access mobile internet in more than 100 countries and areas. Leveraging its inventive cloud SIM technology and architecture, the company redefine the mobile data connectivity experience, allowing users to gain access to mobile data traffic allowance shared by network operators on its marketplace. It has aggregated mobile data traffic allowances from 391 MNOs in 163 countries and regions in its cloud SIM architecture. The company derives maximum revenue from Japan.